Recent News
Here you will find recent C-Path news events. Please feel free to browse the documents and news releases below to learn more about what we are doing at Critical Path Institute. Click here to download a Press Kit.
Recent News...
June 2010 - Critical Path Institute's Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
June 2010 - Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative DiseasesA new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials will be released today by the Coalition Against Major Diseases (CAMD).
A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute's Predictive Safety Testing Consortium's evaluation of seven kidney biomarkers for use in drug safety assessment.
April 2010 - Critical Path Institute President/CEO Receives Award of Excellence
Raymond L. Woosley, MD, PhD, President/CEO of Tucson-based Critical Path Institute (CPI), was recently presented with the prestigious 2010 PhRMA Foundation Award in Excellence in Clinical Pharmacology at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
March 2010 - Critical Path Institute Continues to Expand
Stephen Joel Coons, PhD, Joins as Director of the newly formed Patient-Reported Outcomes Consortium
March 2010 - Global Partners Join Forces to Speed Development of New TB Drug Combinations
FDA applauds effort to take years off development of much needed TB treatments
January 2010 - C-Path's Rick Myers appointed to the Arizona Board of Regents
Governor Jan Brewer today appointed one new member to the Arizona Board of Regents, Tucson resident Rick Myers.
Recently the Carcinogenicity Working Group of The Critical Path Institute's Predictive Safety Testing Consortium used TaqMan® Gene Expression Assays and Arrays to both validate and extend existing microarray data generated to predict non-genotoxic carcinogens that chemically induce hepatic tumorigenicity in rats.
March 2009 - Critical Path Institute adds two strategic hires: Beatriz Rendón and Steven Broadbent...Beatriz Rendón and Steven Broadbent have joined the Critical Path Institute (C-Path) as the independent non-profit organization continues to grow and execute its mission of creating collaborations that result in improved testing methods that accelerate development of safe, new medical products.
February 2009 - C-Path researchers crack diseases through math, info sharing...
This week, Inside Tucson Business debuts a new monthly feature which profiles the work of young scientists. The idea is to showcase the work and projects of budding scientists, engineers, doctors and researchers.
January 2009 - C-Path names respected business executive to lead its operations...
Richard T. Myers, a former senior executive with engineering expertise at IBM, has been named Chief Operating Officer of the nonprofit Critical Path Institute, its founder and CEO, Dr. Ray Woosley, announced.